Hirata Eishu, Sahai Erik
Department of Oncologic Pathology, Kanazawa Medical University, Ishikawa 920-0293, Japan.
Tumor Cell Biology Laboratory, Francis Crick Institute, London WC2A 3LY, United Kingdom.
Cold Spring Harb Perspect Med. 2017 Jul 5;7(7):a026781. doi: 10.1101/cshperspect.a026781.
Cancer evolution plays a key role in both the development of tumors and their response to therapy. Like all evolutionary processes, tumor evolution is shaped by the environment. In tumors, this consists of a complex mixture of nontransformed cell types and extracellular matrix. Chemotherapy or radiotherapy imposes further strong selective pressures on cancer cells during cancer treatment. Here, we review how different components of the tumor microenvironment can modulate the response to chemo- and radiotherapy. We further describe how therapeutic strategies directly alter the composition, or function, of the tumor microenvironment, thereby further altering the selective pressures to which cancer cells are exposed. Last, we explore the consequences of these interactions for therapy outcomes and how to exploit our increasing understanding of the tumor microenvironment for therapeutic benefit.
癌症演变在肿瘤的发展及其对治疗的反应中都起着关键作用。与所有进化过程一样,肿瘤进化受环境影响。在肿瘤中,这种环境由未转化的细胞类型和细胞外基质的复杂混合物组成。化疗或放疗在癌症治疗期间会对癌细胞施加进一步强大的选择压力。在此,我们综述肿瘤微环境的不同组成部分如何调节对化疗和放疗的反应。我们还描述了治疗策略如何直接改变肿瘤微环境的组成或功能,从而进一步改变癌细胞所面临的选择压力。最后,我们探讨这些相互作用对治疗结果的影响,以及如何利用我们对肿瘤微环境日益加深的理解来实现治疗益处。